Publikationen von Eze, Chukwuka

Zur erweiterten Suche

Eine Ebene höher

Gruppiert nach: Dokumententyp | Veröffentlichungsdatum

Springe zu: Zeitschriftenartikel

Anzahl der Publikationen: 65

Zeitschriftenartikel

Käsmann, Lukas; Eze, Chukwuka; Taugner, Julian; Nieto, Alexander; Hofstetter, Kerstin; Kröninger, Sophie; Guggenberger, Julian; Kenndoff, Saskia; Flörsch, Benedikt; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus

und Manapov, Farkhad (2023): Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study. In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 10: S. 7393-7403 [PDF, 1MB]

Holzgreve, Adrien

; Taugner, Julian; Käsmann, Lukas; Müller, Philipp; Tufman, Amanda; Reinmuth, Niels; Li, Minglun; Winkelmann, Michael; Unterrainer, Lena M.; Nieto, Alexander E.; Bartenstein, Peter; Kunz, Wolfgang G.

; Ricke, Jens; Belka, Claus

; Eze, Chukwuka

; Unterrainer, Marcus und Manapov, Farkhad (2023): Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 50, Nr. 8: S. 2466-2476 [PDF, 1MB]

Hofstetter, Kerstin; Taugner, Julian

; Käsmann, Lukas; Mansoorian, Sina; Flörsch, Benedikt; Eze, Chukwuka; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus

und Manapov, Farkhad (2023): First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis. In: Strahlentherapie und Onkologie [Forthcoming] [PDF, 465kB]

Rabe, Moritz

; Palacios, Miguel A.; van Sörnsen de Koste, John R.; Eze, Chukwuka

; Hillbrand, Martin; Belka, Claus; Landry, Guillaume

; Senan, Suresh

und Kurz, Christopher (2023): Comparison of MR‐guided radiotherapy accumulated doses for central lung tumors with non‐adaptive and online adaptive proton therapy. In: Medical Physics, Bd. 50, Nr. 5: S. 2625-2636 [PDF, 474kB]

Eze, Chukwuka

; Friedrich, Isabelle; Hadi, Indrawati; Schmidt-Hegemann, Nina-Sophie; Hartoyo, Sarah Nindya; Trauth, Richard; Reitz, Daniel; Manapov, Farkhad; Siefert, Axel; Dreyling, Martin; Belka, Claus und Li, Minglun (2022): Primary radiation therapy in stage I/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysis. In: European Journal of Haematology, Bd. 109, Nr. 1: S. 21-30 [PDF, 1MB]

Taugner, Julian; Käsmann, Lukas; Karin, Monika; Eze, Chukwuka; Flörsch, Benedikt; Guggenberger, Julian; Li, Minglun; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad (2022): Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition. In: Investigational new drugs, Bd. 40: S. 163-171 [PDF, 1MB]

Eze, Chukwuka

; Guggenberger, Julian Elias; Schmidt-Hegemann, Nina-Sophie; Kenndoff, Saskia; Taugner, Julian; Käsmann, Lukas; Schönecker, Stephan; Floersch, Benedikt; Li, Minglun; Belka, Claus und Manapov, Farkhad (2022): Pooled analysis on image-guided moderately hypofractionated thoracic irradiation in inoperable node-positive/recurrent patients with non-small cell lung cancer with poor prognostic factors and severely limited pulmonary function and reserve. In: Cancer, Bd. 128, Nr. 12: S. 2358-2366 [PDF, 220kB]

Flörsch, Benedikt; Taugner, Julian; Käsmann, Lukas; Kenndoff, Saskia; Guggenberger, Julian; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad (2022): Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy +/- immune checkpoint inhibition: a decade-long single-center historical analysis. In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 7: S. 3267-3276 [PDF, 1MB]

Nierer, Lukas; Eze, Chukwuka; Mendes, Vanessa da Silva; Braun, Juliane; Thum, Patrick; Bestenbostel, Rieke von; Kurz, Christopher; Landry, Guillaume; Reiner, Michael; Niyazi, Maximilian; Belka, Claus und Corradini, Stefanie (2022): Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate. In: Radiation Oncology, Bd. 17, Nr. 1 [PDF, 946kB]

Käsmann, Lukas; Taugner, Julian; Eze, Chukwuka; Nieto, Alexander; Pelikan, Carolyn; Flörsch, Benedikt; Kenndoff, Saskia; Hofer, Thomas P.; Nössner, Elfriede; Schulz, Christian; Unterrainer, Marcus; Tufman, Amanda; Klauschen, Frederick; Jung, Andreas; Neumann, Jens; Kumbrink, Jorg; Reinmuth, Niels; Bartenstein, Peter; Belka, Claus und Manapov, Farkhad (2022): Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker study. In: Translational Lung Cancer Research, Bd. 11, Nr. 7: S. 1503-1509 [PDF, 294kB]

Manapov, Farkhad; Eze, Chukwuka; Holzgreve, Adrien; Käsmann, Lukas; Nieto, Alexander; Taugner, Julian und Unterrainer, Marcus (2022): PET/CT for Target Delineation of Lung Cancer Before Radiation. In: Seminars in Nuclear Medicine, Bd. 52, Nr. 6: S. 673-680

Hadi, Indrawati; Eze, Chukwuka; Schoenecker, Stephan; Bestenbostel, Rieke von; Rogowski, Paul; Nierer, Lukas; Bodensohn, Raphael; Reiner, Michael; Landry, Guillaume; Belka, Claus; Niyazi, Maximilian und Corradini, Stefanie (2022): MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience. In: Radiation Oncology, Bd. 17, Nr. 1, 8

Eze, Chukwuka; Lombardo, Elia; Nierer, Lukas; Xiong, Yuqing; Niyazi, Maximilian; Belka, Claus; Manapov, Farkhad und Corradini, Stefanie (2022): MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients. In: Radiation Oncology, Bd. 17, Nr. 1, 43

Bodensohn, Raphael; Kasmann, Lukas; Eze, Chukwuka; Pazos, Montserrat; Belka, Claus und Manapov, Farkhad (2022): Timing of tumor-induced atelectasis resolution and pulmonary function restoration in the course of image-guided moderate hypofractionated thoracic irradiation: a case report and mini-review of literature. In: BJR Case Reports, Bd. 8, Nr. 1, 20200168

Schmidt-Hegemann, Nina-Sophie; Zamboglou, Constantinos; Thamm, Reinhard; Eze, Chukwuka; Kirste, Simon; Spohn, Simon; Li, Minglun; Stief, Christian; Bolenz, Christian; Schultze-Seemann, Wolfgang; Bartenstein, Peter; Prasad, Vikas; Ganswindt, Ute; Grosu, Anca-Ligia; Belka, Claus; Mayer, Benjamin und Wiegel, Thomas (1. Oktober 2021): A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic Fossa. In: Frontiers in Oncology, Bd. 11, 723536 [PDF, 9MB]

Kretschmer, Alexander; Milow, Johanna; Eze, Chukwuka; Buchner, Alexander; Li, Minglun; Westhofen, Thilo; Fuchs, Frederik; Rogowski, Paul; Trapp, Christian; Ganswindt, Ute; Zacherl, Mathias Johannes; Beyer, Leonie; Wenter, Vera; Bartenstein, Peter; Schlenker, Boris; Stief, Christian G.; Belka, Claus und Schmidt-Hegemann, Nina-Sophie (21. Juni 2021): Patient-Reported and Oncological Outcomes of Salvage Therapies for PSMA-Positive Nodal Recurrent Prostate Cancer: Real-Life Experiences and Implications for Future Trial Design. In: Frontiers in Oncology, Bd. 11, 708595 [PDF, 518kB]

Taugner, Julian; Käsmann, Lukas; Eze, Chukwuka; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad (2021): Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World Setting. In: Cancers, Bd. 13, Nr. 7, 1613

Rogowski, Paul; Trapp, Christian; von Bestenbostel, Rieke; Eze, Chukwuka; Ganswindt, Ute; Li, Minglun; Unterrainer, Marcus; Zacherl, Mathias J.; Ilhan, Harun; Beyer, Leonie; Kretschmer, Alexander; Bartenstein, Peter; Stief, Christian; Belka, Claus und Schmidt-Hegemann, Nina-Sophie (2021): Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy. In: European journal of nuclear medicine and molecular imaging [PDF, 1MB]

Unterrainer, Marcus; Taugner, Julian; Käsmann, Lukas; Tufman, Amanda; Reinmuth, Niels; Li, Minglun; Mittlmeier, Lena M.; Bartenstein, Peter; Kunz, Wolfgang G.; Ricke, Jens; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad (2021): Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition. In: European journal of nuclear medicine and molecular imaging [PDF, 848kB]

Eze, Chukwuka; Schmidt-Hegemann, Nina-Sophie; Sawicki, Lino Morris; Kirchner, Julian; Roengvoraphoj, Olarn; Kaesmann, Lukas; Mittlmeier, Lena M.; Kunz, Wolfgang G.; Tufman, Amanda; Dinkel, Julien; Ricke, Jens; Belka, Claus; Manapov, Farkhad und Unterrainer, Marcus (2021): PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 48, Nr. 12: S. 3975-3989

Kauffmann-Guerrero, Diego; Taugner, Julian; Eze, Chukwuka; Kaesmann, Lukas; Li, Minglun; Tufman, Amanda und Manapov, Farkhad (2021): Clinical Management and Outcome of Grade III Pneumonitis after Chemoradioimmunotherapy for Inoperable Stage III Non-Small Cell Lung Cancer-A Prospective Longitudinal Assessment. In: Diagnostics, Bd. 11, Nr. 11, 1968

Pazos, Montserrat; Eze, Chukwuka; Kahnert, Kathrin; Delius, Maria; Tufman, Amanda; Alba-Alejandre, Irene; Unterrainer, Marcus; Neumann, Jens; Kirchner, Thomas und Manapov, Farkhad (2021): Novel Multimodal Management of Post-Partum Synchronous Metastatic Pulmonary EBV-Associated Lymphoepithelioma-Like Carcinoma (LELC)-A Case Report. In: Diagnostics, Bd. 11, Nr. 11, 2072

Rogowski, Paul; Trapp, Christian; von Bestenbostel, Rieke; Eze, Chukwuka; Ganswindt, Ute; Li, Minglun; Unterrainer, Marcus; Zacherl, Mathias J.; Ilhan, Harun; Beyer, Leonie; Kretschmer, Alexander; Bartenstein, Peter; Stief, Christian; Belka, Claus und Schmidt-Hegemann, Nina-Sophie (2021): Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 49, Nr. 4: S. 1417-1428

Schnoeller, Leon; Kaesmann, Lukas; Taugner, Julian; Abdo, Reem; Eze, Chukwuka und Manapov, Farkhad (2021): Prognostic Role of Lung Immune Scores for Prediction of Survival in Limited-stage Small Cell Lung Cancer. In: In Vivo, Bd. 35, Nr. 2: S. 929-935

Eze, Chukwuka; Schmidt-Hegemann, Nina-Sophie; Sawicki, Lino Morris; Kirchner, Julian; Roengvoraphoj, Olarn; Käsmann, Lukas; Mittlmeier, Lena M.; Kunz, Wolfgang G.; Tufman, Amanda; Dinkel, Julien; Ricke, Jens; Belka, Claus

; Manapov, Farkhad und Unterrainer, Marcus (2021): PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions. In: European journal of nuclear medicine and molecular imaging [PDF, 3MB]

Taugner, Julian; Käsmann, Lukas; Eze, Chukwuka; Rühle, Alexander; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus

und Manapov, Farkhad (2021): Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients. In: Investigational new drugs, Bd. 39: S. 1189-1196 [PDF, 586kB]

Taugner, Julian; Kaesmann, Lukas; Eze, Chukwuka; Ruehle, Alexander; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad (2021): Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients. In: Investigational New Drugs, Bd. 39, Nr. 4: S. 1189-1196

Taugner, Julian; Käsmann, Lukas; Karin, Monika; Eze, Chukwuka; Flörsch, Benedikt; Guggenberger, Julian; Li, Minglun; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad (2021): Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition. In: Investigational New Drugs, Bd. 40, Nr. 1: S. 163-171

Unterrainer, Marcus; Taugner, Julian; Kasmann, Lukas; Tufman, Amanda; Reinmuth, Niels; Li, Minglun; Mittlmeier, Lena M.; Bartenstein, Peter; Kunz, Wolfgang G.; Ricke, Jens; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad (2021): Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy +/- immune checkpoint inhibition. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 49, Nr. 4: S. 1407-1416

Roengvoraphoj, Olarn; Kaesmann, Lukas; Eze, Chukwuka; Taugner, Julian; Gjika, Arteda; Tufman, Amanda; Hadi, Indrawati; Li, Minglun; Mille, Erik; Gennen, Kathrin; Belka, Claus und Manapov, Farkhad (2020): Maximum standardized uptake value of primary tumor (SUVmax_PT) and horizontal range between two most distant PET-positive lymph nodes predict patient outcome in inoperable stage III NSCLC patients after chemoradiotherapy. In: Translational Lung Cancer Research, Bd. 9, Nr. 3: S. 541-548

Manapov, Farkhad; Käsmann, Lukas; Roengvoraphoj, Olarn; Belka, Claus

und Eze, Chukwuka

(2020): Multimodal “synergistic” treatment based on tumour immunological contexture for advanced non‐driver non‐small cell lung cancer: A myth or reality? In: European Journal of Cancer Care, Bd. 29, Nr. 5 [PDF, 196kB]

Kaesmann, Lukas; Eze, Chukwuka; Taugner, Julian; Roengvoraphoj, Olarn; Dantes, Maurice; Schmidt-Hegemann, Nina-Sophie; Schiopu, Sanziana; Belka, Claus und Manapov, Farkhad (2020): Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy. In: Radiation Oncology, Bd. 15, Nr. 1, 167

Schmidt Hegemann, Nina-Sophie; Rogowski, Paul; Eze, Chukwuka; Schafer, Christian; Stief, Christian; Lang, Sebastian; Spohn, Simon; Steffens, Rieke; Li, Minglun; Gratzke, Christian; Schultze-Seemann, Wolfgang; Ilhan, Harun; Fendler, Wolfgang Peter; Bartenstein, Peter; Ganswindt, Ute; Buchner, Alexander; Grosu, Anca-Ligia; Belka, Claus; Meyer, Philipp Tobias; Kirste, Simon und Zamboglou, Constantinos (2020): Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair Analysis. In: Cancers, Bd. 12, Nr. 11, 3395

Karin, Monika; Taugner, Julian; Kaesmann, Lukas; Eze, Chukwuka; Roengvoraphoj, Olarn; Tufman, Amanda; Belka, Claus und Manapov, Farkhad (2020): Association of Planning Target Volume with Patient Outcome in Inoperable Stage III NSCLC Treated with Chemoradiotherapy: A Comprehensive Single-Center Analysis. In: Cancers, Bd. 12, Nr. 10, 3035

Hoffmann, Michael; Reitz, Daniel; Taugner, Julian; Roengvoraphoj, Olarn; Kaesmann, Lukas; Eze, Chukwuka; Karin, Monika; Belka, Claus und Manapov, Farkhad (2020): Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy. In: Anticancer Research, Bd. 40, Nr. 4: S. 2319-2322

Kaesmann, Lukas; Eze, Chukwuka; Taugner, Julian; Roengvoraphoj, Olarn; Belka, Claus und Manapov, Farkhad (2020): Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)-a German radiation oncology survey. In: Translational Lung Cancer Research, Bd. 9, Nr. 2: S. 288-293

Taugner, Julian; Eze, Chukwuka; Kaesmann, Lukas; Roengvoraphoj, Olarn; Gennen, Kathrin; Karin, Monika; Petrukhnov, Oleg; Tufman, Amanda; Belka, Claus und Manapov, Farkhad (2020): Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer. In: Radiation Oncology, Bd. 15, Nr. 1, 148

Gennen, Kathrin; Kaesmann, Lukas; Taugner, Julian; Eze, Chukwuka; Karin, Monika; Roengvoraphoj, Olarn; Neumann, Jens; Tufman, Amanda; Orth, Michael; Reu, Simone; Belka, Claus und Manapov, Farkhad (2020): Prognostic value of PD-L1 expression on tumor cells combined with CD8+TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy. In: Radiation Oncology, Bd. 15, Nr. 1, 5

Martin, Ole; Bruckmann, Nils-Martin; Kirchner, Julian; Ullrich, Tim; Ingenwerth, Marc; Bogner, Simon; Eze, Chukwuka; Nensa, Felix; Herrmann, Ken; Umutlu, Lale; Antoch, Gerald und Sawicki, Lino M. (2020): Is there a connection between immunohistochemical markers and grading of lung cancer with apparent diffusion coefficient (ADC) and standardised uptake values (SUV) of hybrid 18F-FDG-PET/MRI? In: Journal of Medical Imaging and Radiation Oncology, Bd. 64, Nr. 6: S. 779-786

Kaesmann, Lukas; Abdo, Reem; Eze, Chukwuka; Dantes, Maurice; Taugner, Julian; Gennen, Kathrin; Roengvoraphoj, Olarn; Rades, Dirk; Belka, Claus und Manapov, Farkhad (2020): External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy. In: Lung, Bd. 198, Nr. 1: S. 201-206

Schmidt-Hegemann, Nina-Sophie; Buchner, Alexander; Eze, Chukwuka; Rogowski, Paul; Schaefer, Christian; Ilhan, Harun; Li, Minglun; Fendler, Wolfgang Peter; Bartenstein, Peter; Ganswindt, Ute; Stief, Christian; Belka, Claus

und Kretschmer, Alexander (2020): PSMA-positive nodal recurrence in prostate cancer. In: Strahlentherapie und Onkologie, Bd. 196: S. 637-646 [PDF, 351kB]

Kaesmann, Lukas; Eze, Chukwuka; Dantes, Maurice; Roengvoraphoj, Olarn; Niyazi, Maximilian; Belka, Claus und Manapov, Farkhad (2019): State of clinical research of radiotherapy/chemoradiotherapy and immune checkpoint inhibitor therapy combinations in solid tumours-a German radiation oncology survey. In: European Journal of Cancer, Bd. 108: S. 50-54

Taugner, Julian; Kaesmann, Lukas; Eze, Chukwuka; Dantes, Maurice; Roengvoraphoj, Olarn; Gennen, Kathrin; Karin, Monika; Petruknov, Oleg; Tufman, Amanda; Belka, Claus und Manapov, Farkhad (2019): Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy. In: Translational Lung Cancer Research, Bd. 8, Nr. 5: S. 593-604

Eze, Chukwuka; Taugner, Julian; Roengvoraphoj, Olarn; Schmidt-Hegemann, Nina-Sophie; Kaesmann, Lukas; Wijaya, Cherylina; Belka, Claus und Manapov, Farkhad (2019): Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis. In: Radiation Oncology, Bd. 14, Nr. 1, 163

Kaesmann, Lukas; Taugner, Julian; Eze, Chukwuka; Roengvoraphoj, Olarn; Dantes, Maurice; Gennen, Kathrin; Karin, Monika; Petrukhnov, Oleg; Tufman, Amanda; Belka, Claus und Manapov, Farkhad (2019): Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment. In: Anticancer Research, Bd. 39, Nr. 9: S. 5077-5081

Schmidt-Hegemann, Nina-Sophie; Eze, Chukwuka; Li, Minglun; Rogowski, Paul; Schäfer, Christian; Stief, Christian; Buchner, Alexander; Zamboglou, Constantinos; Fendler, Wolfgang Peter; Ganswindt, Ute; Cyran, Clemens; Bartenstein, Peter; Belka, Claus und Ilhan, Harun (2019): Impact of Ga-68-PSMAPET/CT on the Radiotherapeutic Approach to Prostate Cancer in Comparison to CT: A Retrospective Analysis. In: Journal of Nuclear Medicine, Bd. 60, Nr. 7: S. 963-970

Schmidt-Hegemann, Nina-Sophie; Stief, Christian; Kim, Tak-Hyun; Eze, Chukwuka; Kirste, Simon; Strouthos, Iosif; Li, Minglun; Schultze-Seemann, Wolfgang; Ilhan, Harun; Fendler, Wolfgang Peter; Bartenstein, Peter; Grosu, Anca-Ligia; Ganswindt, Ute; Belka, Claus; Meyer, Philipp T. und Zamboglou, Constantinos (2019): Outcome After PSMA PET/CT-Based Salvage Radiotherapy in Patients with Biochemical Recurrence After Radical Prostatectomy: A 2-Institution Retrospective Analysis. In: Journal of Nuclear Medicine, Bd. 60, Nr. 2: S. 227-233

Manapov, Farkhad; Käsmann, Lukas; Roengvoraphoj, Olarn; Dantes, Maurice; Schmidt-Hegemann, Nina-Sophie; Belka, Claus und Eze, Chukwuka (2018): Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes. In: Lung Cancer-Targets and Therapy, Bd. 9: S. 49-55 [PDF, 163kB]

Kasmann, Lukas; Niyazi, Maximilian; Blanck, Oliver; Baues, Christian; Baumann, Rene; Dobiasch, Sophie; Eze, Chukwuka; Fleischmann, Daniel; Gauer, Tobias; Giordano, Frank A.; Goy, Yvonne; Hausmann, Jan; Henkenberens, Christoph; Kaul, David; Klook, Lisa; Krug, David; Mäurer, Matthias; Panje, Cedric M.; Rosenbrock, Johannes; Sautter, Lisa; Schmitt, Daniela; Suess, Christoph; Thieme, Alexander H.; Trommer-Nestler, Maike; Ziegler, Sonia; Ebert, Nadja; Medenwald, Daniel und Ostheimer, Christian (2018): Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer A systematic review. In: Strahlentherapie und Onkologie, Bd. 194, Nr. 2: S. 79-90

Roengvoraphoj, Olarn; Wijaya, Cherylina; Eze, Chukwuka; Li, Minglun; Dantes, Maurice; Taugner, Julian; Tufman, Amanda; Huber, Rudolf Maria; Belka, Claus und Manapov, Farkhad (2018): Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer. In: Strahlentherapie und Onkologie, Bd. 194, Nr. 2: S. 107-115

Roengvoraphoj, Olarn; Eze, Chukwuka; Wijaya, Cherylina; Dantes, Maurice; Taugner, Julian; Tufman, Amanda; Huber, Rudolf Maria; Bartenstein, Peter; Belka, Claus und Manapov, Farkhad (2018): How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 45, Nr. 12: S. 2103-2109

Schmidt-Hegemann, Nina-Sophie; Fendler, Wolfgang Peter; Ilhan, Harun; Herlemann, Annika; Buchner, Alexander; Stief, Christian; Eze, Chukwuka; Rogowski, Paul; Li, Minglun; Bartenstein, Peter; Ganswindt, Ute und Belka, Claus (2018): Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy. In: Radiation Oncology 13:37 [PDF, 670kB]

Manapov, Farkhad; Roengvoraphoj, Olarn; Dantes, Maurice; Marschner, Sebastian; Li, Minglun und Eze, Chukwuka (2018): Pneumonitis in Irradiated Lungs After Nivolumab: A Brief Communication and Review of the Literature. In: Journal of Immunotherapy, Bd. 41, Nr. 2: S. 96-99 [PDF, 174kB]

Eze, Chukwuka; Roengvoraphoj, Olarn; Dantes, Maurice; Abdo, Reem; Kaesmann, Lukas; Schmidt-Hegemann, Nina-Sophie; Belka, Claus und Manapov, Farkhad (2018): Prophylactic Cranial Irradiation for Patients with Small Cell Lung Cancer in Germany: Pattern of Care Survey. In: Anticancer Research, Bd. 38, Nr. 9: S. 5261-5265

Eze, Chukwuka; Roengvoraphoj, Olarn; Niyazi, Maximilian; Hildebrandt, Guido; Fietkau, Rainer; Belka, Claus und Manapov, Farkhad (2017): Treatment Response and Prophylactic Cranial Irradiation Are Important Prognostic Factors in LD SCLC Patients Staged with cMRI. In: Journal of thoracic Oncology, Bd. 12, Nr. 1: S1470-S1471

Eze, Chukwuka; Hegemann, Nina-Sophie; Roengvoraphoj, Olarn; Dantes, Maurice und Manapov, Farkhad (2017): Concurrent Afatinib and Whole-Brain Radiotherapy in Exon 19-del-EGFR Mutant Lung Adenocarcinoma: A Case Report and Mini Review of the Literature. In: Frontiers in Oncology, Bd. 7, 88 [PDF, 947kB]

Manapov, Farkhad und Eze, Chukwuka (2017): Prophylactic cranial irradiation in small-cell lung cancer. In: Lancet Oncology, Bd. 18, Nr. 7, E366-E366

Manapov, Farkhad; Roengvoraphoj, Olarn und Eze, Chukwuka (2017): Why is survival after pembrolizumab affected by previous radiotherapy? In: Lancet Oncology, Bd. 18, Nr. 9, E504-E504

Eze, Chukwuka; Roengvoraphoj, Olarn; Dantes, Maurice und Manapov, Farkhad (2017): Is it time to convert the frequency of radiotherapy in small-cell lung cancer? In: Lancet Oncology, Bd. 18, Nr. 10, E555-E555

Schmidt-Hegemann, Nina-Sophie; Fendler, Wolfgang Peter; Buchner, Alexander; Stief, Christian; Rogowski, Paul; Niyazi, Maximilian; Eze, Chukwuka; Li, Minglun; Bartenstein, Peter; Belka, Claus und Ganswindt, Ute (2017): Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy. In: Radiation Oncology 12:176 [PDF, 2MB]

Roengvoraphoj, Olarn; Eze, Chukwuka; Niyazi, Maximilian; Li, Minglun; Hildebrandt, Guido; Fietkau, Rainer; Belka, Claus und Manapov, Farkhad (2017): Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy. In: Strahlentherapie und Onkologie, Bd. 193, Nr. 2: S. 150-155

Manapov, Farkhad; Roengvoraphoj, Olarn; Li, Minglun und Eze, Chukwuka (2017): Moderate hypofractionated image-guided thoracic radiotherapy for locally advanced node-positive non-small cell lung cancer patients with very limited lung function: a case report. In: Radiation Oncology Journal, Bd. 35, Nr. 2: S. 180-184 [PDF, 390kB]

Eze, Chukwuka; Roengvoraphoj, Olarn und Manapov, Farkhad (2017): Prophylactic Cranial Irradiation in Resected Early-Stage Small Cell Lung Cancer. In: International Journal of Radiation Oncology Biology Physics, Bd. 98, Nr. 3: S. 612-614

Manapov, Farkhad; Eze, Chukwuka; Niyazi, Maximilian; Roengvoraphoj, Olarn; Li, Minglun; Hegemann, Nina-Sophie; Hildebrandt, Guido; Fietkau, Rainer und Belka, Claus (2016): Investigating a Correlation between Chemoradio-therapy Schedule Parameters and Overall Survival in a real-life LD SCLC Patient Cohort. In: Journal of Cancer, Bd. 7, Nr. 14: S. 2012-2017

Manapov, Farkhad; Niyazi, Maximilian; Gerum, Sabine; Roengvoraphoj, Olarn; Eze, Chukwuka; Li, Minglun; Hildebrandt, Guido; Fietkau, Rainer; Klautke, Gunther und Belka, Claus (2016): Evaluation of the role of remission status in a heterogeneous limited disease small-cell lung cancer patient cohort treated with definitive chemoradiotherapy. In: BMC Cancer 16:216 [PDF, 757kB]

Diese Liste wurde am Sat Dec 21 23:48:50 2024 CET erstellt.

Exportieren als	RSS 1.0 RSS 2.0